High costs, lack of insurance contribute to low rate of colorectal cancer screenings in U.S.
High out-of-pocket costs, lack of health insurance and limited access to care contribute to a relatively low rate of colorectal cancer screening in the United States, according to a new systematic review by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.
The racial gap in colon cancer death rates is widening, a new report says, and experts partly blame blacks' lower screening rates and poor access to quality care.